Precision radiation may cut side effects in cervical cancer

NCT ID NCT05880485

Ongoing Disease control Sponsor: Peking Union Medical College Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests online adaptive radiotherapy, a type of radiation that adjusts in real-time to target cervical cancer more precisely. By using smaller treatment margins, doctors hope to reduce side effects while still effectively treating the tumor. The trial involves 30 adults with newly diagnosed cervical cancer and will measure both patient-reported and physician-reported side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: online adaptive radiotherapy (a type of radiation therapy that adjusts in real-time to target the tumor more precisely)
What this could lead to: If successful, this approach could reduce side effects from radiation for cervical cancer patients, making treatment more tolerable.
What could go wrong: This is an early-phase study with only 30 participants, so results may not apply to all patients. The reduced margins might also increase the risk of missing cancer cells.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer cervical carcinoma Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

UTERINE CERVICAL NEOPLASM

Contacts and locations

Locations

Peking Union Medical College Hospital

Beijing, Beijing Municipality, 100730, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.